Jerónimo Rafael Rodríguez‐Cid

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Alexander Luft, David Vicente et al. · New England Journal of Medicine · 2018 · 3.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto et al. · The Lancet · 2021 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +14

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Luis Paz‐Ares, David Vicente, Ali Tafreshi et al. · Journal of Thoracic Oncology · 2020 · 645 citations · Full text

Medicine, Oncology, Pharmacology +14

Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Silvia Novello, Dariusz M. Kowalski, Alexander Luft et al. · Journal of Clinical Oncology · 2023 · 512 citations · Full text

Medicine, Oncology, Pharmacology +17

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Taofeek K. Owonikoko, Keunchil Park, Ramaswamy Govindan et al. · Journal of Clinical Oncology · 2021 · 267 citations · Full text

Medicine, Oncology, Pharmacotherapy +16